Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours
1996
Effect of Emitefur and Radiation on Tumors
Sample size: 10
publication
Evidence: moderate
Author Information
Author(s): Y Shibamoto, R Murata, S Miyauchi, M Hirohashi, T Takagi, K Sasai, T Shibata, N Oya, M Takahashi
Primary Institution: Kyoto University
Hypothesis
What is the combined effect of emitefur and radiation on murine tumors?
Conclusion
Emitefur has a significant anti-tumor effect when given alone or with radiation at clinically relevant doses.
Supporting Evidence
- Emitefur alone did not produce significant anti-tumor effects at lower doses.
- Combination of 25 mg/kg emitefur with radiation resulted in a significant increase in tumor growth delay.
- Four out of ten mice treated with ten fractions of 25 mg/kg emitefur plus radiation were cured.
Takeaway
Emitefur, a new cancer drug, works better when combined with radiation to help shrink tumors in mice.
Methodology
The study used murine tumor models to assess the effects of emitefur and radiation on tumor growth delay.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
All mice were female and 10 weeks old at the start of treatment.
Statistical Information
P-Value
0.015
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website